🚀 go-pugleaf

Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press Review (February 16, 2013) – Revue de presse (16 février 2013)


Study Points to Shorter Treatments for Prostate Cancer
Men with high-risk prostate cancer treated with only 18 months of
hormone therapy live just as long as those treated for a more standard
36 months, a new study has found.
By Andrew Pollack. In The New York Times
http://www.nytimes.com/2013/02/13/business/prostate-cancer-study-suggests-shorter-treatments.html?_r=0

Report Faults Priorities in Studying Breast Cancer
Too little of the money the federal government spends on breast cancer
research goes toward finding environmental causes of the disease and
ways to prevent it, according to a new report from a group of
scientists, government officials and patient advocates established by
Congress to examine the research.
By Denise Grady. In The New York Times
http://www.nytimes.com/2013/02/12/health/report-faults-priorities-in-breast-cancer-research.html

Protein Central to Cancer Stem Cell Formation Provides New Potential
Target
Researchers have identified a pivotal protein in a cellular
transformation that makes a cancer cell more resistant to treatment
and more capable of growing and spreading, making it an inviting new
target for drug development.
In Science Daily
http://www.sciencedaily.com/releases/2013/02/130213131940.htm

Childhood Cancer Survivors Who Received Chest Irradiation at Risk for
Pulmonary Hypertension in Middle Age
St. Jude Children's Research Hospital investigators found evidence
that chest irradiation may leave some adult survivors of childhood
cancer in danger of developing pulmonary hypertension in middle age.
In Science Daily
http://www.sciencedaily.com/releases/2013/02/130213114506.htm

Lung cancer set to overtake breast cancer as the main cause of cancer
deaths among European women
Lung cancer is likely to overtake breast cancer as the main cause of
cancer death among European women by the middle of this decade,
according to new research published in the cancer journal Annals of
Oncology [1] today (Wednesday). In the UK and Poland it has already
overtaken breast cancer as the main cause of cancer deaths in women.
In EurekAlert (press release)
http://www.eurekalert.org/pub_releases/2013-02/esfm-lcs021113.php

Emerging Cancer Drugs May Drive Bone Tumors
Cancer drugs should kill tumors, not encourage their spread. But new
evidence suggests that an otherwise promising class of drugs may
actually increase the risk of tumors spreading to bone, according to
researchers at Washington University School of Medicine in St. Louis.
In Science Daily
http://www.sciencedaily.com/releases/2013/02/130213092238.htm

Researchers Discover Biological Diversity in Triple-Negative Breast
Cancer
Triple-negative breast cancers are more biologically diverse than
previously believed and classification should be expanded to reflect
this heterogeneity, according to University of North Carolina
researchers.
In Science Daily
http://www.sciencedaily.com/releases/2013/02/130213114509.htm

Copper depletion therapy keeps high-risk triple-negative breast cancer
at bay
An anti-copper drug compound that disables the ability of bone marrow
cells from setting up a "home" in organs to receive and nurture
migrating cancer tumor cells has shown surprising benefit in one of
the most difficult-to-treat forms of cancer -- high-risk triple-
negative breast cancer.
In EurekAlert (press release)
http://www.eurekalert.org/pub_releases/2013-02/wcmc-cdt020813.php

Eradicating Bacteria Linked to Gastric Cancer
In an analysis of the results of interventions to eradicate the
bacterium Helicobacter pylori (a risk factor for gastric cancer) in
seven diverse community populations in Latin America, researchers
found that geographic site, demographic factors, adherence to initial
therapy and infection recurrence may be as important as the choice of
antibiotic regimen in H pylori eradication interventions, according to
a study appearing in the February 13 issue of JAMA.
In Science Daily
http://www.sciencedaily.com/releases/2013/02/130212172001.htm


Le cancer du poumon explose chez la femme
En 2015, le cancer du poumon tuera plus de femmes en Europe que le
cancer du sein. Ce sombre pronostic est issu de projections publiées
mercredi dans les Annals of Oncology.
Par Delphine Chayet. Dans Le Figaro
http://sante.lefigaro.fr/actualite/2013/02/13/19844-cancer-poumon-explose-chez-femme

Amiante : 18 000 à 25 000 décès par cancer de la plèvre d'ici 2030
Le pic des décès dus au mésothéliome (cancer de la plèvre) aurait en
fait déjà été atteint, selon des travaux réalisés par l'InVS en
partenariat avec le Centre d'épidémiologie sur les causes médicales de
décès (CépiDc) de l'Inserm.
Dans Le Point
http://www.lepoint.fr/sante/amiante-18-000-a-25-000-deces-par-cancer-de-la-plevre-12-02-2013-1626900_40.php

Cancer : un virus modifié suscite l'espoir d'un nouveau traitement
Un virus génétiquement modifié pour cibler les cellules tumorales
vient de montrer qu’il augmentait significativement l’espérance de vie
de patients en phase terminale du cancer du foie. Nommé Pexa-Vec et
testé également pour d’autres cancers, il semblerait là encore plutôt
efficace. Si tout se passe bien, il pourrait être proposé d’ici 5 ans.
Dans Futura Sciences
http://www.futura-sciences.com/fr/news/t/medecine/d/cancer-un-virus-modifie-suscite-lespoir-dun-nouveau-traitement_44563/

Des nanoparticules d'or radioactives contre le cancer
Les noyaux d’hélium produits par radioactivité alpha sont très
efficaces pour tuer des cellules cancéreuses. Ils le sont
malheureusement aussi pour tuer les cellules saines, ce qui a
jusqu’ici posé problème pour lutter contre les cancers. On apprend
comment contourner l'obstacle grâce aux nanotechnologies : en
utilisant des nanoparticules d’or.
Dans Futura Sciences
 http://www.futura-sciences.com/fr/news/t/physique-1/d/des-nanoparticules-dor-radioactives-contre-le-cancer_44460/









Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com













Marc Lacroix-Corman – InTextoResearch – Baelen  (02/2013)